Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.
- Resource Type
- Article
- Authors
- Alton, Eric W F W; Armstrong, David K; Ashby, Deborah; Bayfield, Katie J; Bilton, Diana; Bloomfield, Emily V; Boyd, A Christopher; Brand, June; Buchan, Ruaridh; Calcedo, Roberto; Carvelli, Paula; Chan, Mario; Cheng, Seng H; Collie, D David S; Cunningham, Steve; Davidson, Heather E; Davies, Gwyneth; Davies, Jane C; Davies, Lee A; Dewar, Maria H
- Source
- Lancet Respiratory Medicine; Sep2015, Vol. 3 Issue 9, p684-691, 8p
- Subject
- CYSTIC fibrosis treatment
GENE therapy
- Language
- ISSN
- 22132600
The article discusses a study which examined the effect of nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy on patients with cystic fibrosis.